Pathway Financial Advisers LLC cut its position in MetLife, Inc. (NYSE:MET – Free Report) by 1.4% in the 3rd quarter, Holdings Channel.com reports. The firm owned 26,311 shares of the financial services provider’s stock after selling 385 shares during the period. Pathway Financial Advisers LLC’s holdings in MetLife were worth $2,189,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of MET. Vanguard Group Inc. raised its position in MetLife by 3.4% in the first quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider’s stock valued at $4,418,612,000 after purchasing an additional 1,974,268 shares during the last quarter. Swedbank AB bought a new position in shares of MetLife during the first quarter worth about $131,456,000. Acadian Asset Management LLC raised its position in shares of MetLife by 7,837.0% during the second quarter. Acadian Asset Management LLC now owns 1,129,353 shares of the financial services provider’s stock worth $79,250,000 after acquiring an additional 1,115,124 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of MetLife by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock worth $378,799,000 after acquiring an additional 988,666 shares during the last quarter. Finally, Bessemer Group Inc. raised its position in shares of MetLife by 29.7% during the first quarter. Bessemer Group Inc. now owns 2,120,275 shares of the financial services provider’s stock worth $157,133,000 after acquiring an additional 485,811 shares during the last quarter. 89.81% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on MET. Citigroup raised their price objective on MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. Wells Fargo & Company raised their price objective on MetLife from $86.00 to $92.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. Keefe, Bruyette & Woods lowered their price objective on MetLife from $86.00 to $85.00 and set an “outperform” rating for the company in a research report on Monday, July 8th. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a research note on Friday, October 4th. Finally, Barclays initiated coverage on MetLife in a research note on Wednesday, September 4th. They issued an “overweight” rating and a $91.00 price target on the stock. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $88.46.
MetLife Trading Down 0.3 %
NYSE MET opened at $82.86 on Wednesday. The company has a market cap of $58.03 billion, a price-to-earnings ratio of 22.33, a P/E/G ratio of 0.70 and a beta of 1.04. MetLife, Inc. has a 52 week low of $58.48 and a 52 week high of $86.94. The business has a 50 day moving average price of $80.21 and a 200-day moving average price of $74.69. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.56.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 EPS for the quarter, beating the consensus estimate of $2.13 by $0.15. The firm had revenue of $17.82 billion during the quarter, compared to the consensus estimate of $18.57 billion. MetLife had a return on equity of 21.41% and a net margin of 4.23%. The company’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.94 earnings per share. As a group, equities analysts expect that MetLife, Inc. will post 8.58 earnings per share for the current fiscal year.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 annualized dividend and a dividend yield of 2.63%. MetLife’s dividend payout ratio is 58.76%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- What is a SEC Filing?
- Double-Digit Gains Ahead? Top 2 Stocks Positioned to Outperform
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Analysts Believe Cassava Sciences Now Has 300% Upside From Here
- Stock Market Upgrades: What Are They?
- These Are The Top Health Stocks to Own for Buy-and-Hold Investing
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.